BackMicroba Life Sciences Limited Overview

Microba Life Sciences Limited Net Income

Microba Life Sciences Limited's net income is $-36M, below the sector sector average of $1.6T.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$10.17M
↓ 10.52% YoY

As of Jun 2026

Annual Net Income (TTM)

-$35.66M
↓ 9.33% YoY

Trailing 12 months ending Jun 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Microba Life Sciences Limited (MAP.AX) FAQ

The latest net income for MAP.AX is $-36M as of June 2026. That compares with $-33M in the prior-year period — down 9.3% year over year. That is below the sector sector average of $1.6T. Investors often review this figure alongside Microba Life Sciences Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, MAP.AX's net income moved from $-33M to $-36M — a 9.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Microba Life Sciences Limited's operating scale or balance-sheet position.

Against its sector companies, MAP.AX currently prints $-36M for net income, while the sector average sits near $1.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Microba Life Sciences Limited's growth, margins, and balance sheet.

A net income figure of $-36M for MAP.AX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $1.6T. Explore the charts below for those layers of context.

After noting MAP.AX's net income ($-36M), review year-over-year change from $-33M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers